https://de.marketscreener.com/kurs/aktie/WEREWOLF-THERAPEUTICS-INC-122186740/news/Werewolf-Therapeutics-Inc-gibt-den-Beginn-der-Patientendosierung-in-der-klinischen-Phase-1-1B-Stud-41678892/?utm_source=telegram&utm_medium=social&utm_campaign=share